Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A
Nikolaos Mavrakanas, Efstratios Mendrinos, Constantin J. Pournaras, Joel SalzmannVolume:
87
Year:
2009
Language:
english
DOI:
10.1111/j.1755-3768.2009.01598.x
File:
PDF, 899 KB
english, 2009